GPR-MV 2 Tablet SR
strip of 10.0 tablet.Prescription required
About this product:
| Salt Composition: | Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg) |
| Manufacturer: | Astrodin Life Science Pvt Ltd |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
GPR-MV 2 Tablet SR is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels. GPR-MV 2 Tablet SR is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
GPR-MV 2 Tablet SR is a combination of three antidiabetic medicines:
What is GPR-MV 2 Tablet SR?
GPR-MV 2 Tablet SR contains a combination of Glimepiride, Metformin, and Voglibose. It is used for the treatment of type 2 diabetes mellitus (DM). This medication helps improve blood glucose levels in adults when taken with proper diet and exercise. Glimepiride reduces blood sugar by increasing insulin release from the pancreas. Metformin lowers glucose production in the liver and improves insulin sensitivity. Voglibose, an alpha-glucosidase inhibitor, works to lower postprandial (after meals) glucose levels. This combination is not for treating Type 1 diabetes mellitus.
What are possible side effects of GPR-MV 2 Tablet SR?
Common side effects associated with GPR-MV 2 Tablet SR include hypoglycemia (low blood sugar level), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection.
Are there specific conditions in which GPR-MV 2 Tablet SR should not be taken?
Avoid use of GPR-MV 2 Tablet SR if you have known allergies to any component or excipient. It is also not recommended for patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis including diabetic ketoacidosis.
Is it safe to drink alcohol while taking GPR-MV 2 Tablet SR?
No, combining GPR-MV 2 Tablet SR with alcohol is not recommended. It may lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Can GPR-MV 2 Tablet SR cause hypoglycemia?
Yes, GPR-MV 2 Tablet SR can cause hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. This is more likely if you miss or delay meals, drink alcohol, exercise excessively, or take other antidiabetic medications with it. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice at all times.
What are the storage and disposal instructions for GPR-MV 2 Tablet SR?
Store this medication in its original packaging, tightly sealed. Follow the directions on the label for proper storage. Do not consume unused medicine. Ensure it is inaccessible to pets, children, and other individuals.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. GPR-MV 2 Tablet SR is to be taken empty stomach.
- Take it with food to lower your chance of having an upset stomach.
- It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal.
- Carry a sugar source with you for immediate relief.
- Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
- No common side effects listed.
Alcohol
It is unsafe to consume alcohol with GPR-MV 2 Tablet SR.
Breastfeed
GPR-MV 2 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy
GPR-MV 2 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
